Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study)

Autor: Elena Levtchenko, Sandrine Florquin, Joanna A.E. van Wijk, Michiel F. Schreuder, Antonia H. M. Bouts, Christa Reefman, Floor Veltkamp, Djera H Khan, Susan T. Veissi, Lotte Haverman, Hedy A. van Oers, Ron A. A. Mathôt

Publikováno v: BMJ Open, 9, 8, pp. e027011
Veltkamp, F, Khan, D H, Reefman, C, Veissi, S, van Oers, H A, Levtchenko, E, Mathôt, R A A, Florquin, S, van Wijk, J A E, Schreuder, M F, Haverman, L & Bouts, A H M 2019, ' Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: Study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study) ', BMJ Open, vol. 9, no. 8, e027011 . https://doi.org/10.1136/bmjopen-2018-027011
BMJ Open, 9(8):e027011. BMJ Publishing Group
BMJ Open
BMJ Open, Vol 9, Iss 8 (2019)
BMJ open, 9(8):e027011. BMJ Publishing Group
BMJ Open, 9, e027011

IntroductionIdiopathic nephrotic syndrome (INS) is characterised by a high relapse rate up to 80% after initial response to standard therapy with corticosteroids. Steroid toxicity is common and causes a great burden of disease that negatively influen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d621f424e3483bb3fb082c6e654a3dea
https://hdl.handle.net/2066/208544